1.
|
Morgan TM, Keegan KA and Clark PE: Bladder
cancer. Curr Opin Oncol. 23:275–282. 2011. View Article : Google Scholar : PubMed/NCBI
|
2.
|
Valastyan S and Weinberg RA: Tumor
metastasis: molecular insights and evolving paradigms. Cell.
147:275–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
3.
|
Saffar H, Sanii S, Heshmat R, et al:
Expression of galectin-3, nm-23, and cyclooxygenase-2 could
potentially discriminate between benign and malignant
pheochromocytoma. Am J Clin Pathol. 135:454–460. 2011. View Article : Google Scholar : PubMed/NCBI
|
4.
|
Kim SH, Lee SY, Park HR, et al: Nuclear
localization of Nm23-H1 in head and neck squamous cell carcinoma is
associated with radiation resistance. Cancer. 117:1864–1873. 2011.
View Article : Google Scholar : PubMed/NCBI
|
5.
|
Polanski R, Maguire M, Nield PC, et al:
MDM2 interacts with NME2 (non-metastatic cells 2, protein), and
suppresses the ability of NME2 to negatively regulate cell
motility. Carcinogenesis. 32:1133–1142. 2011. View Article : Google Scholar : PubMed/NCBI
|
6.
|
Jiang WX, Song BG and Wang PJ: Expression
of nm23, KAI1 and spiral computed tomography findings in primary
gallbladder carcinoma. Chin Med J (Engl). 122:2666–2668.
2009.PubMed/NCBI
|
7.
|
Boissan M and Lacombe ML: NM23, an example
of a metastasis suppressor gene. Bull Cancer. 99:431–440. 2012.(In
French).
|
8.
|
Cao GL, Chu MX, Fang L, et al: Analysis on
DNA sequence of KiSS-1 gene and its association with litter size in
goats. Mol Biol Rep. 37:3921–3929. 2010. View Article : Google Scholar : PubMed/NCBI
|
9.
|
Hiney JK, Srivastava VK and Les Dees W:
Insulin-like growth factor-1 stimulation of hypothalamic KiSS-1
gene expression is mediated by Akt: effect of alcohol.
Neuroscience. 166:625–632. 2010. View Article : Google Scholar : PubMed/NCBI
|
10.
|
Lee KH and Kim JR: Kiss-1 suppresses MMP-9
expression by activating p38 MAP kinase in human stomach cancer.
Oncol Res. 18:107–116. 2009. View Article : Google Scholar : PubMed/NCBI
|
11.
|
Shoji I, Hirose T, Mori N, et al:
Expression of kisspeptins and kisspeptin receptor in the kidney of
chronic renal failure rats. Peptides. 31:1920–1925. 2010.
View Article : Google Scholar : PubMed/NCBI
|
12.
|
Moon HG, Jeong SH, Ju YT, et al:
Up-regulation of RhoGDI2 in human breast cancer and its prognostic
implications. Cancer Res Treat. 42:151–156. 2010. View Article : Google Scholar : PubMed/NCBI
|
13.
|
Zheng Z, Li J, He X, et al: Involvement of
RhoGDI2 in the resistance of colon cancer cells to 5-fluorouracil.
Hepatogastroenterology. 57:1106–1112. 2010.PubMed/NCBI
|
14.
|
Niu H, Li H, Xu C and He P: Expression
profile of RhoGDI2 in lung cancers and role of RhoGDI2 in lung
cancer metastasis. Oncol Rep. 24:465–471. 2010.PubMed/NCBI
|
15.
|
Su J, You JF, Wang JL, et al:
Overexpression of tumor metastasis suppressor gene 1 suppresses
proliferation and invasion, but enhances apoptosis of human breast
cancer cells MDA-MB-231 cells. Zhonghua Bing Li Xue Za Zhi.
36:672–676. 2007.(In Chinese).
|
16.
|
Su J, You JF, Wang JL, et al:
Overexpression of human tumor metastasis-related gene TMSG-1
suppresses cell proliferation and invasion of a highly metastatic
prostate cancer cell line PC-3M-1E8 in vitro. Zhonghua Zhong Liu Za
Zhi. 30:404–407. 2008.(In Chinese).
|
17.
|
Chen SH, Bubb MR, Yarmola EG, et al:
Vacuolar H+-ATPase binding to microfilaments: regulation
in response to phosphatidylinositol 3-kinase activity and detailed
characterization of the actin-binding site in subunit B. J Biol
Chem. 279:7988–7998. 2004.PubMed/NCBI
|
18.
|
Schiffmann S, Sandner J, Birod K, et al:
Ceramide synthases and ceramide levels are increased in breast
cancer tissue. Carcinogenesis. 30:745–752. 2009. View Article : Google Scholar : PubMed/NCBI
|
19.
|
Wang H, Wang J, Zuo Y, et al: Expression
and prognostic significance of a new tumor metastasis suppressor
gene LASS2 in human bladder carcinoma. Med Oncol. 29:1921–1927.
2012. View Article : Google Scholar : PubMed/NCBI
|
20.
|
Wang H, Yang D, Wang K and Wang J:
Expression and potential role of chemokine receptor CXCR4 in human
bladder carcinoma cell lines with different metastatic ability. Mol
Med Rep. 4:525–528. 2011.PubMed/NCBI
|
21.
|
Yang D, Wang H, Wang J, et al:
Establishment of a fluorescent implantation metastasis model of
bladder cancer and real-time microscopic detection in nude mice.
Asian Pac J Cancer Prev. 12:393–396. 2011.PubMed/NCBI
|
22.
|
Girnita A, All-Ericsson C, Economou MA, et
al: The insulin-like growth factor-I receptor inhibitor
picropodophyllin causes tumor regression and attenuates mechanisms
involved in invasion of uveal melanoma cells. Clin Cancer Res.
12:1383–1391. 2006. View Article : Google Scholar
|
23.
|
Masek T, Vopalensky V, Suchomelova P and
Pospisek M: Denaturing RNA electrophoresis in TAE agarose gels.
Anal Biochem. 336:46–50. 2005. View Article : Google Scholar : PubMed/NCBI
|
24.
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
25.
|
Baron V, Adamson ED, Calogero A, et al:
The transcription factor Egr1 is a direct regulator of multiple
tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin.
Cancer Gene Ther. 13:115–124. 2006. View Article : Google Scholar : PubMed/NCBI
|
26.
|
Calogero A, Arcella A, De Gregorio G, et
al: The early growth response gene EGR-1 behaves as a suppressor
gene that is down-regulated independent of ARF/Mdm2 but not p53
alterations in fresh human gliomas. Clin Cancer Res. 7:2788–2796.
2001.PubMed/NCBI
|
27.
|
Liotta LA, Steeg PS and Stetler-Stevenson
WG: Cancer metastasis and angiogenesis: an imbalance of positive
and negative regulation. Cell. 64:327–336. 1991. View Article : Google Scholar : PubMed/NCBI
|
28.
|
Ichikawa T, Ichikawa Y and Isaacs JT:
Genetic factors and meta-static potential of prostatic cancer.
Cancer Surv. 11:35–42. 1991.
|